Looking forward to the #AdolRheum22 symposium today. I will talk about the use of AI and ML in rheumatic disease.
4
Pierre Dönnes retweeted
SciCross is part of the “Biomedical AI-driven data analytics” (BIO-AID) part of this 51 million sek research funding. mynewsdesk.com/se/his/pressr… (in Swedish only)
“Nightswimming deserves a quiet night....”
#aftersauna #seasidecamper #mittÅåå instagram.com/p/Bz3wMNuIRJrg…
Flight rescheduled, ending up at a the EGG London AI conference instead. Great talks so far! #EGGLDN2019 #AI #ML
Pierre Dönnes retweeted
Pierre Dönnes retweeted
New paper on immunogenicity risk in MS patients treated with Interferon beta published in JCI Insight, scicross.com/2018/06/16/immu…. #immunogenicity #MS #ABIRISK
Pierre Dönnes retweeted
New publication on on protein de-immunization, together with Harvard Medical school and the University of Tubingen.
#immunogenicity #FVIII #computationalimmunology
scicross.com/2018/05/02/dual…
Nice work from the ABIRISK consortium #abirisk #immunogenicity @SciCross teapaw.org/SciCross/status/844153…
Innovativa startups våren 2017 - Vinnova. Nice to be on that list! vinnova.se/sv/misc/menyer-oc…
1
I'll be there. Check out "An Evening w/ Hjalmar Winbladh + Startup Matchmaking 2017" eventbrite.com/e/an-evening-… @Eventbrite
1
Pierre Dönnes retweeted
New paper from the ABIRISK consortium dx.doi.org/10.1371/journal.p… #abirisk @IMI_JU #immunogenicity
Looking forward to two days of #NLSdays in Stockholm. #personalizedmedicine @DataVergeTDA @SciCross #immunogenicity
Schysst start-up atmosfär på @timberyarduk. Koffeinet behövs också. #caffeineaddict.
Getting ready for venture capital days in Gothenburg #Connect2capital.
So proud to be from Sweden:
Experience the power of a bookbook™: youtu.be/MOXQo7nURs0 via @YouTube


